Key result
Anesthetic and sedative choice significantly alters echocardiographic measurements in rat cardiomyopathy models.
Why the study?
How do different anesthetic and sedative protocols affect echocardiographic parameters in rat models of cardiomyopathy?
How do different anesthetic and sedative protocols affect echocardiographic parameters in rat models of cardiomyopathy?
The choice of anesthetic or sedative protocol represents a critical, yet insufficiently standardized, methodological variable that can significantly bias echocardiographic assessments of cardiac contractility and autonomic function in rat models of cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Anesthesia choice may confound echocardiographic measures in rat cardiomyopathy models; leaves open need for standardized protocols in future studies.
Cardiomyopathies represent a heterogeneous group of diseases that lead to functional and structural impairment of the myocardium, frequently culminating in heart failure. Due to ethical and technical constraints inherent to human studies, rat models have become indispensable in experimental cardiology. Transthoracic echocardiography represents one of the most commonly used methods for assessing cardiac structure and function in experimental rat models of cardiomyopathy, due to its accessibility, non-invasiveness, ease of use, safety and cost-effectiveness. Almost all echocardiographic examinations in rats require a certain level of pharmacological sedation or general anesthesia to immobilize the animal and reduce motion-induced artifacts. A review of the literature reveals that only a few anesthetics are used in experimental practice. By far the two most prevalent choices are isoflurane and the ketamine-xylazine combination. Less frequently used are pentobarbital, the tiletamine-zolazepam combination, sevoflurane, and acepromazine. However, the interpretation of echocardiographic findings in experimental animals can be significantly biased by the effects of anesthesia primarily on the autonomic nervous system and cardiac contractility. Therefore the choice of anesthetic or sedative protocol represents an important, yet insufficiently standardized, methodological variable in the echocardiographic assessment of rat models of cardiomyopathy. Here we discuss the bias introduced by the use of sedatives/anesthetics when performing echocardiography in different rat models of experimental cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Pajović et al. (2026) conducted a review in Experimental cardiomyopathy (rat models). Anesthetics and sedatives (e.g., isoflurane, ketamine-xylazine, pentobarbital, tiletamine-zolazepam, sevoflurane, acepromazine) during transthoracic echocardiography was evaluated on Echocardiographic parameters of cardiac structure and function. Anesthetics and sedatives (most commonly isoflurane and ketamine-xylazine) significantly bias echocardiographic parameters in rat cardiomyopathy models via autonomic and contractile effects.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: